The board of MEI Pharma (US:MEIP), a San Diego-based oncology company, is under fire from prominent shareholders who argue that a proposed merger with Infinity Pharmaceuticals (US:INFI) undervalues ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results